ACE |
Angiotensin converting enzyme |
APACC |
Association pour la Prevention par l’Aspirine du Cancer Colorectal |
APC |
Adenomatous polyposis coli |
ASA |
Aspirin |
BCL-2 |
B-cell lymphoma 2 |
CAPP2 |
The Colorectal/Adenoma/Carcinoma Prevention Programme 2 |
CAPS |
Colorectal Adenoma Prevention Study |
CHIP |
Clonal hematopoiesis of indeterminate potential; Children’s International Polyposis |
COX |
Cyclooxygenase |
CRC |
Colorectal cancer |
DFMO |
Difluoromethylornitine |
DNA |
Deoxyribonucleic acid |
FAP |
Familial adenocarcinoma polyposis |
HIF-1α |
Hypoxia-inducible factor 1-alpha |
HNPCC |
Hereditary non-polyposis colorectal cancer |
IL-1β |
Leukocytic pyrogen |
IL-6 |
Interleukin 6 |
IL-23 |
Interleukin 23 |
ITT |
Intention-to-treat analysis |
IκB |
Inhibitor of nuclear factor kappa B |
NF-κB |
Nuclear factor-kappa B |
NSAIDs |
Non-steroidal anti-inflammatory drugs |
PGHS |
Prostaglandin endoperoxide synthase |
PPARs |
Peroxisome proliferator-activated receptors |
PreSAP |
Prevention of Colorectal Sporadic Adenomatous Polyps |
STAT3 |
Signal transducer and activator of transcription 3 |
RNA |
Ribonucleic acid |
TDP |
Time to disease progression |
TNF-α |
Tumor necrosis factor-alpha |
WHS |
Women’s Health Study |
15-LOX-1 |
15-Lipooxygenase 1 |